1tl3

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1tl3" size="450" color="white" frame="true" align="right" spinBox="true" caption="1tl3, resolution 2.80&Aring;" /> '''Crystal structure o...)
Next diff →

Revision as of 12:25, 8 November 2007


1tl3, resolution 2.80Å

Drag the structure with the mouse to rotate

Crystal structure of hiv-1 reverse transcriptase in complex with gw450557

Overview

We have used a structure-based approach to design a novel series of, non-nucleoside inhibitors of HIV-1 RT (NNRTIs). Detailed analysis of a, wide range of crystal structures of HIV-1 RT-NNRTI complexes together with, data on drug resistance mutations has identified factors important for, tight binding of inhibitors and resilience to mutations. Using this, approach we have designed and synthesized a novel series of quinolone, NNRTIs. Crystal structure analysis of four of these compounds in complexes, with HIV-1 RT confirms the predicted binding modes. Members of this, quinolone series retain high activity against the important resistance, mutations in RT at Tyr181Cys and Leu100Ile.

About this Structure

1TL3 is a Protein complex structure of sequences from Human immunodeficiency virus 1 with PO4 and H20 as ligands. Active as RNA-directed DNA polymerase, with EC number 2.7.7.49 Full crystallographic information is available from OCA.

Reference

Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1., Hopkins AL, Ren J, Milton J, Hazen RJ, Chan JH, Stuart DI, Stammers DK, J Med Chem. 2004 Nov 18;47(24):5912-22. PMID:15537346

Page seeded by OCA on Thu Nov 8 14:31:34 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools